Cargando…
Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis
Importance/Background: The coronavirus disease (COVID-19) pandemic is a critical public health issue. Evidence has shown that metformin favorably influences COVID-19 outcomes. This study aimed to assess the benefits and risks of metformin in COVID-19 patients. Methods: We searched the PubMed, Embase...
Autores principales: | Li, Yin, Yang, Xue, Yan, Peijing, Sun, Tong, Zeng, Zhi, Li, Sheyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416892/ https://www.ncbi.nlm.nih.gov/pubmed/34490296 http://dx.doi.org/10.3389/fmed.2021.704666 |
Ejemplares similares
-
Metformin Treatment and Homocysteine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zhang, Qianying, et al.
Publicado: (2016) -
Bibliometric Analysis and Systematic Review of Global Coronavirus Research Trends Before COVID-19: Prospects and Implications for COVID-19 Research
por: Yan, Peijing, et al.
Publicado: (2021) -
Vitamin B(12) Status in Metformin Treated Patients: Systematic Review
por: Liu, Qilin, et al.
Publicado: (2014) -
Association between splenectomy and chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis
por: Zhang, Liyan, et al.
Publicado: (2021) -
Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review
por: Tan, Jixue, et al.
Publicado: (2021)